Search Results - "Krynetski, Eugene Y."

Refine Results
  1. 1
  2. 2

    Structure and Dynamics of Thioguanine-modified Duplex DNA by Somerville, Lilla, Krynetski, Eugene Y, Krynetskaia, Natalia F, Beger, Richard D, Zhang, Weixing, Marhefka, Craig A, Evans, William E, Kriwacki, Richard W

    Published in The Journal of biological chemistry (10-01-2003)
    “…Mercaptopurine and thioguanine, two of the most widely used antileukemic agents, exert their cytotoxic, therapeutic effects by being incorporated into DNA as…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Msh2 deficiency attenuates but does not abolish thiopurine hematopoietic toxicity in msh2-/- mice by Krynetskaia, Natalia F, Brenner, Timothy L, Krynetski, Eugene Y, Du, Weinan, Panetta, John C, Ching-Hon, Pui, Evans, William E

    Published in Molecular pharmacology (01-08-2003)
    “…The amount of MSH2 protein, a major component of the mismatch repair system, was found to differ >10-fold in leukemia cells from children with newly diagnosed…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Polymorphism of the Thiopurine S-Methyltransferase Gene in African-Americans by Hon, Yuen Yi, Fessing, Michael Y., Pui, Ching-Hon, Relling, Mary V., Krynetski, Eugene Y., Evans, William E.

    Published in Human molecular genetics (01-02-1999)
    “…The molecular basis for the genetic polymorphism of thiopurine S-methyltransferase (TPMT) has been established for Caucasians, but it remains to be elucidated…”
    Get full text
    Journal Article
  7. 7

    Enhanced Proteolysis of Thiopurine S-methyltransferase (TPMT) Encoded by Mutant Alleles in Humans (TPMT3A, TPMT2): Mechanisms for the Genetic Polymorphism of TPMT Activity by Tai, Hung-Liang, Krynetski, Eugene Y., Schuetz, Erin G., Yanishevski, Yuri, Evans, William E.

    “…TPMT is a cytosolic enzyme that catalyzes the S-methylation of aromatic and heterocyclic sulfhydryl compounds, including medications such as mercaptopurine and…”
    Get full text
    Journal Article
  8. 8

    Pharmacogenetics as a molecular basis for individualized drug therapy : The thiopurine S-methyltransferase paradigm by KRYNETSKI, E. Y, EVANS, W. E

    Published in Pharmaceutical research (01-03-1999)
    “…Genetic polymorphism of drug metabolizing enzymes can be the major determinant of inter-individual differences in drug disposition and effects. In this…”
    Get full text
    Journal Article
  9. 9

    Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance by Krynetski, E Y, Evans, W E

    Published in Pharmacology (01-09-2000)
    “…The activity of thiopurine S-methyltransferase (TPMT) is inherited as an autosomal co-dominant trait. In most large world populations studied to date,…”
    Get more information
    Journal Article
  10. 10
  11. 11

    A Single Point Mutation Leading to Loss of Catalytic Activity in Human Thiopurine S-Methyltransferase by Krynetski, Eugene Y., Schuetz, John D., Galpin, Amy J., Pui, Ching-Hon, Relling, Mary V., Evans, William E.

    “…Thiopurine S-methyltransferase (TPMT; S-adenosyl-L-methionine:thiopurine S-methyltransferase, EC 2.1.1.67) activity exhibits genetic polymorphism, with ≈0.33%…”
    Get full text
    Journal Article
  12. 12

    A novel protein complex distinct from mismatch repair binds thioguanylated DNA by Krynetski, E Y, Krynetskaia, N F, Gallo, A E, Murti, K G, Evans, W E

    Published in Molecular pharmacology (01-02-2001)
    “…To elucidate molecular mechanism(s) of cellular response to mercaptopurine, a widely used antileukemic agent, we assessed mercaptopurine (MP) sensitivity in…”
    Get more information
    Journal Article
  13. 13

    Human RNase H-mediated RNA cleavage from DNA-RNA duplexes is inhibited by 6-deoxythioguanosine incorporation into DNA by Krynetskaia, N F, Krynetski, E Y, Evans, W E

    Published in Molecular pharmacology (01-10-1999)
    “…Mercaptopurine and thioguanine are anticancer and immunosuppressive agents that exert their primary cytotoxic effects via incorporation of deoxythioguanosine…”
    Get more information
    Journal Article
  14. 14

    Thioguanine substitution alters DNA cleavage mediated by topoisomerase II by Krynetskaia, Natalia F., Cai, Xiangjun, Nitiss, John L., Krynetski, Eugene Y., Relling, Mary V.

    Published in The FASEB journal (01-11-2000)
    “…Thiopurines and topoisomerase II‐targeted drugs (e.g., etoposide) are widely used anticancer drugs. However, topoisomerase II‐targeted drugs can cause acute…”
    Get full text
    Journal Article
  15. 15

    Molecular haplotyping of genomic DNA for multiple single-nucleotide polymorphisms located kilobases apart using long-range polymerase chain reaction and intramolecular ligation by MCDONALD, Oliver G, KRYNETSKI, Eugene Y, EVANS, William E

    Published in Pharmacogenetics (London) (01-03-2002)
    “…Genetic polymorphisms are well-recognized causes of interindividual differences in disease risk and treatment response in humans. For genes containing multiple…”
    Get full text
    Journal Article
  16. 16

    Promoter and intronic sequences of the human thiopurine S-methyltransferase (TPMT) gene isolated from a human PAC1 genomic library by KRYNETSKI, E. Y, FESSING, M. Y, YATES, C. R, SUN, D, SCHUETZ, J. D, EVANS, W. E

    Published in Pharmaceutical research (01-12-1997)
    “…To isolate and characterize the polymorphic human thiopurine S-methyltransferase (TPMT) gene. The human TPMT gene was isolated by PCR screening of a phage…”
    Get full text
    Journal Article
  17. 17

    Deoxythioguanosine triphosphate impairs HIV replication: a new mechanism for an old drug by KRYNETSKAIA, NATALIA F., FENG, JOY Y., KRYNETSKI, EUGENE Y., GARCIA, J. VICTOR, PANETTA, JOHN C., ANDERSON, KAREN S., EVANS, WILLIAM E.

    Published in The FASEB journal (01-09-2001)
    “…Inhibition of HIV‐1 reverse transcriptase (RT) and HIV protease are effective mechanisms for anti‐retroviral agents, and the combined use of mechanistically…”
    Get full text
    Journal Article
  18. 18

    Molecular cloning and functional characterization of the cDNA encoding the murine thiopurine S-methyltransferase (TPMT) by Fessing, Michael Y, Belkov, Vladimir M, Krynetski, Eugene Y, Evans, William E

    Published in FEBS letters (13-03-1998)
    “…Thiopurine S-methyltransferase (TPMT) is a cytosolic enzyme that catalyzes S-methylation of aromatic and heterocyclic sulfhydryl compounds, including…”
    Get full text
    Journal Article
  19. 19

    Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus by Relling, Mary V., Hancock, Michael L., Rivera, Gaston K., Sandlund, John T., Ribeiro, Raul C., Krynetski, Eugene Y., Pui, Ching-Hon, Evans, William E.

    “…BACKGROUND: Patients with acute lymphoblastic leukemia are often treated with 6-mercaptopurine, and those with homozygous deficiency in thiopurine…”
    Get full text
    Journal Article
  20. 20

    Molecular diagnosis of thiopurine S-methyltransferase deficiency : Genetic basis for azathioprine and mercaptopurine intolerance by YATES, C. R, KRYNETSKI, E. Y, LOENNECHEN, T, FESSING, M. Y, TAI, H.-L, PUI, C.-H, RELLING, M. V, EVANS, W. E

    Published in Annals of internal medicine (15-04-1997)
    “…Thiopurine S-methyltransferase (TPMT) catalyzes the S-methylation (that is, inactivation) of mercaptopurine, azathioprine, and thioguanine and exhibits genetic…”
    Get full text
    Journal Article